- Home
- DSS vs RDHL Comparison
DSS vs RDHL Comparison
Compare DSS & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DSS | RDHL |
|---|---|---|
| Founded | 1984 | 2009 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1M | 3.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DSS | RDHL |
|---|---|---|
| Price | $0.96 | $1.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.5K | ★ 66.1K |
| Earning Date | 11-14-2025 | 09-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $22,046,000.00 | $9,550,000.00 |
| Revenue This Year | $14.93 | $381.91 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 6.53 | ★ 157.62 |
| 52 Week Low | $0.72 | $1.01 |
| 52 Week High | $1.90 | $7.00 |
Technical Indicators
Market Signals| Indicator | DSS | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 41.31 | 44.31 |
| Support Level | $0.92 | $1.10 |
| Resistance Level | $0.99 | $1.23 |
| Average True Range (ATR) | 0.05 | 0.05 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 58.62 | 28.25 |
Price Performance
Historical ComparisonAbout DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.